
Available to mentor

Elliot B. Tapper MD is an Associate Professor in the Division of Gastroenterology and Hepatology. He is Academic Chief of Hepatology. His primary goal is to empower patients to enjoy a high quality of life. He is an expert in the management of chronic liver disease, performance of clinical trials, and big data for the study of liver disease. He has developed strategies that reduce symptoms and improve quality of life and invented tools that have helped keep patients with cirrhosis at home and away from the hospital. He is the Editor-in-Chief of Hepatology Communications.
-
Center MemberInstitute for Healthcare Policy and Innovation
-
Center MemberPrecision Health Initiative
-
Center MemberEisenberg Family Depression Center
Dr. Tapper's research aims to improve the outcomes, quality of life, and freedom from adverse events for patients with cirrhosis. His research is funded by the National Institutes of Health, Patient Centered Research Outcomes Institute, and Industry. He has led randomized trials to improve quality of life, prevent falls and hepatic encephalopathy, examine mind-body methods for symptom control, and evaluate food-as-medicine to treat cirrhosis and control symptoms. He is an expert in quality improvement interventions, medical decision making modeling, and big data analysis.
-
Tapper E. 2025 Apr 8;PresentationQuality of Life in Cirrhosis
-
Ferrarese A, Hurtado Díaz De León I, Tapper EB, Burra P. Hepatology Communications, 2025 Apr 3; 9 (4):Journal ArticleSexual health and function in liver disease
DOI:10.1097/HC9.0000000000000691 -
Ingebrigtson M, Schang S, Hyzy RC, McSparron JI, Chen X, Tapper EB, Kenes MT. Journal of Pharmacy Practice, 2025 Apr 1; 38 (2): 231 - 236.Journal ArticlePhenobarbital Versus Benzodiazepines for Alcohol Withdrawal in the Medical Intensive Care Unit (ICU): A Retrospective Cohort Study
DOI:10.1177/08971900241273144 PMID: 39262224 -
Grady J, Song M, Townsend W, Mahmud N, Tapper EB, Parikh ND. Hepatology Communications, 2025 Mar 24; 9 (4):Journal ArticleA systematic review of noninvasive laboratory indices and elastography to predict hepatic decompensation
DOI:10.1097/HC9.0000000000000675 PMID: 40131017 -
Tapper E. 2025 Mar 4;PresentationPatient Reported Outcomes
-
Tapper E. 2025 Mar 4;PresentationSymptoms of Cirrhosis
-
Tapper E. 2025 Mar 4;PresentationThe Future of Hepatology
-
Tapper E. 2025 Mar 4;PresentationGround Rounds: Patient Reported Outcomes

